These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 12380485)
21. Echo-planar and gradient-echo diffusion MRI of normal brain iron in the globus pallidus. Sener RN Clin Imaging; 2002; 26(6):371-4. PubMed ID: 12427429 [TBL] [Abstract][Full Text] [Related]
28. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. Barzó P; Marmarou A; Fatouros P; Hayasaki K; Corwin F J Neurosurg; 1997 Dec; 87(6):900-7. PubMed ID: 9384402 [TBL] [Abstract][Full Text] [Related]
29. Metabolic crisis in maple syrup urine disease: an unusual complication of a rare disease: a case report. Doshi HP; Vachharajani HH; Tchan MC; Nasreddine MA; Billmore KE Anaesth Intensive Care; 2024 Jan; 52(1):64-68. PubMed ID: 37994838 [TBL] [Abstract][Full Text] [Related]
30. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy]. Qu SQ; Yang LC; Luan Z; Du K; Yang H Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398 [TBL] [Abstract][Full Text] [Related]
31. Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Heindel W; Kugel H; Wendel U; Roth B; Benz-Bohm G Pediatr Radiol; 1995; 25(4):296-9. PubMed ID: 7567243 [TBL] [Abstract][Full Text] [Related]
32. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease. Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302 [TBL] [Abstract][Full Text] [Related]
33. Maple Syrup Urine Disease Decompensation Presenting as Papilloedema. Culleton S; Siddiqui A Can J Neurol Sci; 2019 Nov; 46(6):780-781. PubMed ID: 31387654 [No Abstract] [Full Text] [Related]
34. Imaging in neonatal maple syrup urine disease. Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353 [No Abstract] [Full Text] [Related]
35. Pattern of restricted diffusion seen on magnetic resonance imaging in maple syrup urine disease. Kar J; Nguyen FN; Moody SB Pediatr Neurol; 2013 Dec; 49(6):505-6. PubMed ID: 24080272 [No Abstract] [Full Text] [Related]
36. Maple syrup disease presenting as paroxysmal dystonia. Temudo T; Martins E; Poças F; Cruz R; Vilarinho L Ann Neurol; 2004 Nov; 56(5):749-50. PubMed ID: 15505779 [No Abstract] [Full Text] [Related]
37. Assessment of vasogenic edema in eclampsia using diffusion imaging. Engelter ST; Provenzale JM; Petrella JR Neuroradiology; 2000 Nov; 42(11):818-20. PubMed ID: 11151687 [TBL] [Abstract][Full Text] [Related]
38. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings. Sener RN Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604 [TBL] [Abstract][Full Text] [Related]
39. CT and MRI in maple syrup urine disease. Uziel G; Savoiardo M; Nardocci N Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354 [TBL] [Abstract][Full Text] [Related]
40. [Diffusion weighted MR: principles and clinical use in selected brain diseases]. Nistri M; Mascalchi M; Moretti M; Tessa C; Politi LS; Orlandi I; Pellicanò G; Villari N Radiol Med; 2000 Dec; 100(6):470-9. PubMed ID: 11307509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]